Neogen Corporation

Last updated September 27, 2026

Organization details

Legal name
Neogen Corporation
Ownership
Public
Status
Active
SIC code
2835 — In Vitro & In Vivo Diagnostic Substances
Jurisdiction of incorporation
Michigan
Headquarters city
Lansing
Headquarters state / province
Michigan
Headquarters country
United States
Fiscal year end
May
Ticker symbol
NEOG
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0000711377
EIN
38-2367843

Board of directors

Chief executives

Since August 2025
John Edward Adent · President & CEO
Until August 2025 · Former

Director election results

Annual meeting of October 23, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 4 other boards.

Network of Neogen Corporation's board connections Agios Pharmaceuticals Inc. Agios Pharmaceuticals... Analog Devices Inc. Analog Devices Inc. Bruker Corporation Bruker Corporation Waystar Holding Corp. Waystar Holding Corp. Aashima Gupta Aashima Gupta Andrea F. Wainer Andrea F. Wainer Jeffrey D. Capello Jeffrey D. Capello Thierry Bernard Thierry Bernard Neogen Corporation
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$7,492
6 purchases by 1 insider
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Aug 19, 2026 Moylan John Patrick Officer (Chief Accounting Officer) Shares withheld for tax −2,365 $11.87 $28,073
Aug 19, 2026 Mikheal Nassif Director, Officer (CEO) Shares withheld for tax −20,397 $11.87 $242,112
Aug 14, 2026 Moylan John Patrick Officer (Chief Accounting Officer) Grant or award +8,584 $11.65 $100,004
Aug 14, 2026 Mikheal Nassif Director, Officer (CEO) Grant or award +141,631 $11.65 $1,650,001
Aug 14, 2026 Richard Bryan Riggsbee Officer (CFO) Grant or award +51,502 $11.65 $599,998
Aug 14, 2026 Jennifer Evans Stacey Officer (Chief Legal Officer) Grant or award +38,627 $11.65 $450,005
Aug 14, 2026 Ranalli Tamara A. Officer (Senior Vice President) Grant or award +25,751 $11.65 $299,999
Aug 4, 2026 Mikheal Nassif Director, Officer (CEO) Open-market purchase +370 $11.81 $4,370
Jun 3, 2026 Moylan John Patrick Officer (Chief Accounting Officer) Shares withheld for tax −2,553 $8.75 $22,339
May 18, 2026 Rocklin Amy M Officer (Former Chief Legal Officer) Option exercise +35,183 $9.29 $326,850
May 18, 2026 Rocklin Amy M Officer (Former Chief Legal Officer) Shares withheld for tax −10,241 $9.29 $95,139
May 4, 2026 Moylan John Patrick Officer (Chief Accounting Officer) Option exercise +4,558 $9.53 $43,438
May 4, 2026 Moylan John Patrick Officer (Chief Accounting Officer) Shares withheld for tax −1,568 $9.53 $14,943
May 1, 2026 Jennifer Evans Stacey Officer (Chief Legal Officer) Grant or award +39,349 $9.53 $374,996
Feb 17, 2026 Mikheal Nassif Director, Officer (CEO) Open-market purchase +23 $10.94 $252

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.